Texas Leads Ibogaine Research for Vets

0:00Texas is stepping up its game on psychedelic research, launching an independent study into IBAGain after drug companies ghosted it there, $50 million offer. Last year, lawmakers poured funds into this for potential treatments on post-traumatic stress disorder and mental health issues, but no pharma bids. Met the bar, so the states taken the wheel solo. Earlier this week, Lieutenant Governor Dan Patrick and House Speaker Dustin Burrows announced the shift, building on the bill, Governor Greg Abbott. Behind back in June, they aimed to fully back the program through the legislature, teaming up with Texas medical squads to push forward. IBAGain comes from an African shrubs route, packing psychedelic punch that's shown promise against opioid addiction, depression, and trauma in spots. Like Mexico and New Zealand, here in the states though, it's locked as a schedule one drug, meaning high abuse risk and no official medical nod yet. A Stanford study last year, tracked 30 special forces vets heading to Mexico for IBAGain

1:02doses paired with magnesium to dodge heart risks, results hit hard, nearly 90 percent drop in PTSD, depression, and anxiety symptoms, plus sharper focus and memory. Now Texas plans to drive this research straight to FDA trials, partnering with local experts to unlock IBAGain's full potential for vets and beyond, keeping the momentum rolling without big pharma holding the reins. Stay informed, with Dallas News Today, AI Powered Updates, I'm Corey with the story.